Endo Inc.

11/18/2024 | Press release | Distributed by Public on 11/18/2024 16:55

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Endo Inc. published this content on November 18, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 18, 2024 at 22:55 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]